In a stunning display of robotic prowess, Boston Dynamics‘ humanoid Atlas robot has successfully navigated the complex task of autonomously picking automotive parts. This demonstration, showcased in a ...

Boston Dynamics' next-generation electic Atlas robot is already hard at work. In a video released Wednesday, the company demonstrated Atlas autonomously picking and placing individual parts ...

On Wednesday, Boston Scientific Corporation (NYSE:BSX) released the results of the primary endpoint of the ACURATE IDE trial of ACURATE neo2 Aortic Valve System for patients with severe ...

Boston Scientific continues to work closely with the U.S. Food and Drug Administration on the regulatory strategy for approval of the ACURATE valve platform in the U.S. The ACURATE neo2 Aortic ...

The latest video, released Wednesday, showcases the robot doing work in a demo space, moving engine parts between bins. Boston Dynamics is quick to note that the actions are being performed ...

Inceptiv is a small device, implanted in the lower torso with leads to the spinal cord, that provides responsive counter-stimulation to relieve chronic pain. The device was approved by the FDA in ...

In a new video caught by TechCrunch, Boston Dynamics’ humanoid robot Atlas can be seen working autonomously in a demo space, sorting engine parts between numbered bins. The company claims that Atlas ...

using spinal cord transcutaneous stimulation (scTS). This promising approach to enhance cardiovascular regulation addresses the challenges of unstable blood pressure and the accompanying ...

Spinal muscular atrophy (SMA) is a disorder affecting the motor neurons—nerve cells that control voluntary muscle movement. These cells are located in the spinal cord. Because the muscles cannot ...

Boston Scientific Corporation (NYSE:BSX) Q3 2024 Earnings Call Transcript October 23, 2024 Boston Scientific Corporation ...

Strong sales of a medical device to treat atrial fibrillation helped lift Boston Scientific’s top line last quarter, but an unexpected pause in an important clinical trial to expand the use of ...